These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12777709)

  • 1. Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Bélanger N; Grégoire L; Bédard P; Di Paolo T
    Endocrine; 2003 Jun; 21(1):97-101. PubMed ID: 12777709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys.
    Bélanger N; Grégoire L; Bédard PJ; Di Paolo T
    Neurobiol Aging; 2006 Nov; 27(11):1684-93. PubMed ID: 16253392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment.
    He L; Di Monte DA; Langston JW; Quik M
    Neuroscience; 2000; 99(4):697-704. PubMed ID: 10974432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine alone and in combination with L-DOPA methyl ester or the D(2) agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H
    Exp Neurol; 1999 Aug; 158(2):414-21. PubMed ID: 10415147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Bankiewicz KS; Oldfield EH; Chiueh CC; Doppman JL; Jacobowitz DM; Kopin IJ
    Life Sci; 1986 Jul; 39(1):7-16. PubMed ID: 3487691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys].
    Chen S
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):50-2, 64. PubMed ID: 1591961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
    Schneider JS; Gonczi H; Decamp E
    Brain Res; 2003 Nov; 990(1-2):38-44. PubMed ID: 14568327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys.
    Domino EF; Ni L; Colpaert F; Marien M
    Recept Channels; 2003; 9(5):335-8. PubMed ID: 14527878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
    Grondin R; Bédard PJ; Britton DR; Shiosaki K
    Neurology; 1997 Aug; 49(2):421-6. PubMed ID: 9270571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR
    J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion.
    Bankiewicz KS; Oldfield EH; Plunkett RJ; Schuette WH; Cogan DG; Hogan N; Zuddas A; Kopin IJ
    Brain Res; 1991 Feb; 541(1):98-102. PubMed ID: 2029630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
    Samadi P; Grégoire L; Bédard PJ
    Neuropharmacology; 2003 Dec; 45(7):954-63. PubMed ID: 14573388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
    Imai H; Nakamura T; Endo K; Narabayashi H
    Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
    Blanchet PJ; Grondin R; Bédard PJ
    Mov Disord; 1996 Jan; 11(1):91-4. PubMed ID: 8771074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion.
    Schneider JS; McLaughlin WW; Roeltgen DP
    Neurology; 1992 Aug; 42(8):1565-72. PubMed ID: 1641154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.